Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12279026 | 0.82 | HPGD (0.61) | HPGDADORA2BSLC2A1KMT2ANPSR1 | |
| SCHEMBL12279036 | 0.80 | HPGD (0.42) | HPGDSLC2A1KMT2ANPSR1KDM4E | |
| SCHEMBL14984335 | 0.78 | BCHE (0.42) | HPGDKMT2ANPSR1KDM4EMAPT | |
| SCHEMBL17722993 | 0.78 | BCHE (0.42) | HPGDKMT2ANPSR1KDM4EMAPT | |
| SCHEMBL12278032 | 0.78 | KMT2A (0.41) | HPGDADORA2BKMT2AKDM4EMAPT | |
| SCHEMBL12278835 | 0.78 | KMT2A (0.41) | HPGDADORA2BKMT2AKDM4EMAPT | |
| SCHEMBL12278467 | 0.75 | KMT2A (0.46) | HPGDSLC2A1KMT2ANPSR1KDM4E | |
| SCHEMBL13444463 | 0.74 | KMT2A (0.53) | ADORA2BKMT2AMAPTLMNAMEN1 | |
| SCHEMBL12279375 | 0.74 | ADORA2B (0.39) | HPGDADORA2BKMT2AKDM4EMAPT | |
| SCHEMBL12278464 | 0.74 | KMT2A (0.45) | HPGDSLC2A1KMT2ANPSR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785915-B2 | Compound for organic thin film transistor and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8785915-B2 | Compound for organic thin film transistor and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) | 2011-09-01 | — | — | US | disclosed |
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | OR10J3, TCF4, CTCF | HPGD 4640/4885ADORA2B 2727/4885SLC2A1 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.